Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase 3 16Phase 1 7Phase 2/3 6Phase 1/2 5Phase NA 4Phase 4 3

Status

Not yet recruiting 2Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 5Head & Neck 1

Conditions

Pancreatic Neoplasms 2Esophageal Squamous Cell Carcinoma 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Esophageal Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × nimotuzumab × Clear all
NCT07535567 2026-04-30

NimoBenSeq

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2/3 Not yet recruiting
386 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01249352 2025-03-31

NICE

Eurofarma Laboratorios S.A.

Phase 2/3 Completed
104 enrolled
Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT06409429 2024-05-10

Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Not yet recruiting
146 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Peking University

Phase 2/3 Withdrawn
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00561990 2015-10-15

Nimotuzumab in Adults With Pancreatic Cancer

Oncoscience AG

Phase 2/3 Completed
188 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01402180 2011-07-26

Nimotuzumab

Fudan University

Phase 2/3 Unknown
128 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡